
Early detection reduces impact of cancer: Servier BeLux commits to screening
« With 50 years of Servier’s presence in Belgium and 40 years in Luxembourg, I have the privilege of leading a dynamic team with a high level of expertise, committed to patients and healthcare professionals. »
Ziad Matta, General Manager Servier BeLux
employees
countries in which
the Group’s medicines
are distributed
of the brand-name revenue
in R&D every year
euros in revenue in 2023/2024
including €4.5 billion for brand-name medicines
and €1.4 billion for generic activities
Oncology, Cardiometabolism & Venous diseases, Neurology
Servier Medical Art is a medical image bank that we make available to illustrate your medical communications.